التفاصيل البيبلوغرافية
| العنوان: |
Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells. |
| المؤلفون: |
Zhu, Zhiyuan, Zhang, Pingde, Li, Ning, Kiang, Karrie Mei Yee, Cheng, Stephen Yin, Wong, Vincent Kam-Wai, Leung, Gilberto Ka-Kit |
| المصدر: |
BioMed Research International; 9/23/2019, p1-12, 12p |
| مصطلحات موضوعية: |
AUTOPHAGY, APOPTOSIS, BIOLOGICAL assay, CANCER chemotherapy, CELL death, CELL lines, CELLULAR signal transduction, COMBINATION drug therapy, DRUG resistance in cancer cells, DRUG synergism, FLOW cytometry, GLIOMAS, TRANSFERASES, WESTERN immunoblotting, TREATMENT effectiveness, LOVASTATIN, SIGNAL peptides, COLONY-forming units assay, TEMOZOLOMIDE, PHARMACODYNAMICS, THERAPEUTICS |
| مستخلص: |
Drug resistance to temozolomide (TMZ) contributes to the majority of tumor recurrence and treatment failure in patients with glioblastoma multiforme (GBM). Autophagy has been reported to play a role in chemoresistance in various types of cancer, including GBM. The anticancer effect of statins is arousing great research interests and has been demonstrated to modulate autophagic function. In this study, we investigated the combinational effects of lovastatin and TMZ on treating U87 and U251 GBM cell lines. Cytotoxicity was measured by MTT and colony formation assays; apoptosis was measured by flow cytometry; the cellular autophagic function was detected by the EGFP-mRFP-LC3 reporter and western blot assay. The results showed that lovastatin might enhance the cytotoxicity of TMZ, increase the TMZ-induced cellular apoptosis, and impair the autophagic flux in GBM cells. Lovastatin triggered autophagy initiation possibly by inhibiting the Akt/mTOR signaling pathway. Moreover, lovastatin might impair the autophagosome-lysosome fusion machinery by suppressing LAMP2 and dynein. These results suggested that lovastatin could enhance the chemotherapy efficacy of TMZ in treating GBM cells. The mechanism may be associated with impaired autophagic flux and thereby the enhancement of cellular apoptosis. Combining TMZ with lovastatin could be a promising strategy for GBM treatment. [ABSTRACT FROM AUTHOR] |
|
Copyright of BioMed Research International is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder